March 1, 2012

Collaborative Research Partnership Announcement

New Angelman Research Collaborative Partnership Announcement The Canadian Angelman Syndrome Society (CASS) and Angelman Syndrome Foundation (ASF) today formally announce a collaborative research partnership to fund the Expert Panel on Challenging and Difficult to Treat Behaviors in Angelman Syndrome (AS). […]

Read more
February 28, 2012

Over $1 Million Invested in Angelman Syndrome Research

Angelman Syndrome Foundation Funds More Than $1 Million in Research Grants for 2009 The Angelman Syndrome Foundation further solidified its dedication to research by increasing its grant award total to more than $1 million for 2009. Most recently, more than […]

Read more
May 23, 2011

Natural History Study and Drug Trial of Levodopa

Natural History Study and Drug Trial of Levodopa at Boston Children’s Hospital Angelman syndrome (AS) is a rare, neurogenetic condition characterized by severe developmental delay, movement disorder, speech impairment (often with a complete lack of speech) and an unusually happy […]

Read more